Search Results 3581-3590 of 17095 for pharmacogenetics
ROCHESTER, Minn. — Mayo Clinic took a pivotal step toward integrating AI solutions in the clinical setting with the deployment of NVIDIA DGX SuperPOD with[...] ...
Considered the most aggressive type of brain cancer, glioblastoma grows rapidly, destroying healthy tissue. Globally, approximately 300,000 people are diagnosed ...
Latest stories · New drug may reduce need for aortic valve surgeries by slowing disease progression featured image · VIDEO: Researchers find caregiving worsens ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
August is National Minority Donor Awareness Month. It's a time of celebrating organ donation and educating people about transplantation by encouraging donor ...
The primary objective of the study is to measure efficacy of saruparib (AZD5305) plus camizestrant compared with physician's choice CDK4/6i plus ET in patients ...
ROCHESTER, Minn. — To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the[ ...
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect ...
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!